OR WAIT null SECS
October 19, 2017
The two companies announced their collaboration for the production and development of cancer vaccines.
October 12, 2017
The companies have entered into a strategic collaboration to establish a new cell therapy and regenerative medicine manufacturing platform, which includes a new manufacturing facility in Belgium.
August 30, 2017
FDA approves Novartis’ CAR-T therapy, marking the first time a cell therapy based on gene transfer has been approved in the United States for any indication.
July 28, 2017
New patent for automated cell processing technology provides commercially viable automated CMC solution for developing CAR-T cell therapies.
April 11, 2017
GE Healthcare continues to ramp up its offerings in the bioprocessing space with the purchase of Asymptote and a continued partnership with Zenith Technologies.
April 02, 2017
The transfer of fluids is governed by different equipment requirements across the medical, biopharma, and cell therapy manufacturing industries.
As regulators strive for balance in cGMPs for cell, gene, and tissue therapies, risk-management principles must guide decisions involving process media and additives.
March 22, 2017
In a FDAVoice blog post, CBER Director Peter Marks discusses the new designation for cell therapies that treat life-threatening diseases.
March 17, 2017
Caladrius is selling the remaining percentage of the subsidiary in order to focus on cell therapy development.
The company announced that it would now be offering a portfolio of fresh and cryopreserved human and animal hepatocytes for ADME-Tox testing.